Achim S. Wannenmacher

Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

D. Gruber, A. Kupsch, H. Reichmann, 2020, Translational Neurodegeneration.

The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry

R. Fleischer, C. Hofer, H. Peters, 2023, BMC Neurology.

Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

O. Witte, D. Gruber, A. Kupsch, 2020, Translational Neurodegeneration.

Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

O. Witte, D. Gruber, A. Kupsch, 2020, Translational Neurodegeneration.